A new form of cancer detection has been found.

Voice of America reports that detecting many forms of cancer may soon be as easy as a simple blood test.

UPI reports that a cancer blood test that detects one molecule of tumor DNA among 10,000 healthy DNA molecules in the blood is promising.

The blood test, developed by researchers at Stanford University School of Medicine could also be used to "monitor the amount of cancer in a patient's body" as well as measure their response to various treatments.

The test for cancer detection is reportedly called CAPP-Seq.

According to researchers, the new method is able to "accurately identify about 50 percent of people in the study with stage-1 lung cancer and all patients whose cancers were more advanced."

Researchers explained that cancer cells "are continuously dividing and dying" and release DNA into the bloodstream as they do.

These "messages in a bottle" can allow better diagnoses and better monitoring of treatment.

This blood test will reportedly go far toward finding the one mutation in 1,000 or 10,000 that comes from cancer cells.

Scott Bratman, an author related to the study, stated, "The vast majority of circulating DNA is from normal, non-cancerous cells, even in patients with advanced cancer."

Bratman continued, "We needed a comprehensive strategy for isolating the circulating DNA from blood and detecting the rare, cancer-associated mutations."

Dr. Abhijit Patel from Yael Cancer Center and Smilow Cancer Hospital stated, "I think it's an important advance in the field. The goal is to detect very small, early stage tumors."

Researches said that the blood test could be used to "screen healthy or at-risk populations for signs of trouble."

The findings of the researchers in regards to this new form of cancer detection will be published online April 6 on Nature Medicine.